Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BIOL

Biolase (BIOL)

Biolase Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOL
DateTimeSourceHeadlineSymbolCompany
17/05/202420:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
17/05/202420:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
17/05/202420:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
17/05/202420:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
14/05/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOLBiolase Inc
14/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
07/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
08/03/202422:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIOLBiolase Inc
05/03/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
28/02/202408:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
24/02/202408:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
22/02/202408:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
21/02/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
16/02/202409:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
15/02/202405:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
14/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIOLBiolase Inc
14/02/202412:03Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
10/02/202400:44Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
07/02/202422:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
07/02/202422:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
31/01/202413:57Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
30/01/202409:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
29/01/202422:30PR Newswire (US)BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024NASDAQ:BIOLBiolase Inc
25/01/202409:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIOLBiolase Inc
19/01/202422:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
09/01/202408:05PR Newswire (US)BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023NASDAQ:BIOLBiolase Inc
04/01/202408:05PR Newswire (US)BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
30/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
27/12/202309:22Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
21/12/202306:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIOLBiolase Inc
 Showing the most relevant articles for your search:NASDAQ:BIOL